These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 guidance the notion of targeting ACKR3 as a singular way to modulate the opioid method, which could open new therapeutic avenues for opioid-associated disorders. At that time, Microsoft Advertising and https://harryy581xuo9.wikinarration.com/user